Myocardial Ischemia Market 2022 Supply-Demand, Industry Research and End User Analysis, Outlook 2027
Market Research Future (MRFR) states in its extensive report
that the global myocardial
ischemia market is set to reach a worth of USD 50,120.3 million during the
forecast period (2017-2023). The increasing cases of coronary artery disease
and diabetes coupled with growing obesity globally are driving the market
growth. On top of that, growing awareness related to heart conditions,
technological advancement in treatments, and rising numbers of hospitals and
healthcare infrastructure around the globe have propelled the myocardial
ischemia market expansion. Moreover, strong economic growth, disposable incomes
of patients, and improved standard of living can fuel the market growth over
the forecast period.
On the other hand, high cost of therapeutic surgeries
impedes the market growth. However, the World Health Organization (WHO) has
been actively launching new initiatives related to heart diseases which will,
in turn, increase awareness and enlighten citizens on matters of heart health.
Various government drives and initiatives are being implemented to address
issues arising from obesity and substance abuse. These actions undertaken by
authorities act as necessary incentive for the global market growth.
Get Sample Report: https://www.marketresearchfuture.com/sample_request/5811
Growing trend in the myocardial ischemia market is
increasing usage of myocardial perfusion imaging. It is a stress test which
relies on imaging of a patient’s heart before and after physical activity to
determine the effects of stress on the flow of blood through the coronary
arteries and the heart muscle.
Global Market for Myocardial Ischemia – Segmental
Analysis
The global myocardial ischemia market is segmented on the
basis of type, diagnosis & treatment, and end-user.
By type, the market is segmented on the basis of symptomatic
and asymptomatic. The asymptomatic (silent) myocardial ischemia segment
accounted for the largest market share in 2017. Growing number of smokers,
family history of heart diseases, prevalence of cases of high cholesterol and
high blood pressure, and lack of exercise can drive the growth in the segment.
By treatment & diagnosis, the market is segmented into
treatment and diagnosis. The diagnosis segment is sub-segmented into imaging
and stress test. On the other hand, the treatment segment is sub-segmented into
medications and surgery. The treatment segment has gained significant traction
owing to increasing prevalence of coronary heart disease and large population
leading a stressful lifestyle. Thus, the treatment segment is estimated to hold
largest market share till the end of the forecast period.
The end-users in the global myocardial ischemia market are
hospitals & clinics, diagnostic centers, ambulatory surgery centers, and
others.
Access Report @ https://www.marketresearchfuture.com/reports/myocardial-ischemia-market-5811
Regional Outlook
Geographically, the global myocardial ischemia market is
spread across the Americas, Europe, Asia Pacific, and the Middle East and
Africa.
MRFR noted that the Americas accounted for the largest
market share and will maintain its dominance throughout the forecast period.
The Americas market is presumed to reach USD 18,130.3 million by 2023 at a CAGR
of 6.21% from 2017 to 2023. This position was achieved due to rising prevalence
of diabetes, obesity, lack of physical inactivity, and excessive alcohol consumption
among the population in the region.
After America, Europe holds the largest market share owing
to high number of cases related to cardiovascular diseases. Revolutionary
technology, rising healthcare infrastructure, continuous researches conducted
to enhance treatment procedures, and easy access to medical facilities and
medication has led to market growth in the region. Moreover, obesity and
stressful schedules have given way to expansion of the market considerably.
Asia Pacific is expected to garner high revenues at the
fastest growth rate of about 6.42% during the forecast period due to rising
prevalence of diabetes. Growing awareness about cardiovascular diseases and
increasing geriatric population are major driving factors of the market in the
region. Moreover, growing economies in the region and rising investments in
healthcare facilities along with a growing number of hospitals make sure that
the market gains significant traction in the region. Apart from these factors,
government initiatives to generate awareness and knowledge regarding health
issues also propel the market growth.
The Middle East and Africa market is estimated to witness
passive growth, which can be attributed to less exposure and access to
healthcare services and stringent government rules and regulations. Moreover,
substandard healthcare infrastructure can deter the growth of the market in the
region.
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment